2 ms·
> I can't get the whole paper, but your first link seems to be saying that we've put all our eggs into one basket and we are ignoring too many other theories. I
by naasking 5y ago
> I can't get the whole paper, but your first link seems to be saying that we've put all our eggs into one basket and we are ignoring too many other theories. It doesn't go so far as to say the amyloid angle is bunk, does it?
Check sci-hub:
https://sci-hub.hkvisa.net/10.1016/j.bcp.2018.09.027 https://sci-hub.hkvisa.net/10.1016/j.bcp.2018.09.027
Quote:
> Furthermore, the blind adherence to the “Amyloid code” [297] has resulted in the overwhelming rationalization of clinical trial failures - the lack of validation of the amyloid hypothesis – as being due to recurring issues in their planning and execution, not that the hypothesis has failed in its validation. This viewpoint, described as “sheer obstinacy in the face of compelling proof ..[of being]… on the wrong track” [285] has also compromised the translational approach to AD therapeutics making the criteria for compound advancement from preclinical research to the clinic exclusively based on either a blind faith in a hypothesis or animal models that have proven irrelevant.
This addresses the special pleading you quoted from people who continue trying to explain away the failures of the amyloid model.
The writing is on the wall, but as they say, "science advances one funeral at a time".